Case Report: Sorafenib-induced rhabdomyolysis in a post-transplant patient with acute myeloid leukemia

This case highlights that sorafenib may cause rare but severe adverse reactions, such as rhabdomyolysis. Clinicians should be vigilant about these potential adverse effects when using sorafenib and enhance patient monitoring and management.